In diabetic kidney tissue, miRNA-181a targets may be a Kruppel-like factor 6 (KLF6) and early growth response factor-1 (EGR-1), which are involved in the disordered proliferation of the glomerular mesangial cells, tubulointerstitial fibrosis, and enhanced cell apoptosis. Here, KLF6 is linked to fibrosis.